Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture

Details for Australian Patent Application No. 2007335212 (hide)

Owner Apotex Technologies Inc.

Inventors Wang, Yingsheng; Leung-Toung, Regis; Zhao, Yanqing; Yu, Lily; Tam, Tim Fat; N'Zemba, Blaise

Agent Fisher Adams Kelly

Pub. Number AU-A-2007335212

PCT Pub. Number WO2008/074128

Priority 2,571,645 19.12.06 CA

Filing date 13 December 2007

Wipo publication date 26 June 2008

International Classifications

C07K 5/037 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 38/05 (2006.01) Medicinal preparations containing peptides - Dipeptides

A61P 17/06 (2006.01) Drugs for dermatological disorders

C07K 1/107 (2006.01) General processes for the preparation of peptides

C07K 1/30 (2006.01) General processes for the preparation of peptides

C07K 5/02 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/074128 Priority application(s): WO2008/074128

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007335216-Inhibitors of histone deacetylase and prodrugs thereof

2007335208-Nucleic acid molecules encoding plant proteins in the C3HC4 family and methods for the alteration of plant cellulose and lignin content